XML 27 R15.htm IDEA: XBRL DOCUMENT v3.7.0.1
Segment and Geographic Information
 6 Months Ended
Jun. 30, 2017
Segment and Geographic Information [Abstract]  
Segment and Geographic Information

10. SEGMENT AND GEOGRAPHIC INFORMATION

The Company evaluates reporting segments in accordance with FASB ASC 280, “Segment Reporting”. The Company develops, manufactures, and sells devices designed primarily for the surgical ablation of cardiac tissue and systems designed for the exclusion of the left atrial appendage. These devices are developed and marketed to a broad base of medical centers globally. Management considers all such sales to be part of a single reportable segment. Revenue attributed to geographic areas is based on the location of the customers to whom products are sold.

Revenue by geographic area was as follows:







 

 

 

 

 

 

 

 

 

 

 

 



 

 

 

 

 

 

 

 

 

 

 

 



 

Three Months Ended

 

Six Months Ended



 

June 30,

 

June 30,



 

2017

 

2016

 

2017

 

2016

United States

 

$

 35,534 

 

$

 30,872 

 

$

 68,802 

 

$

 59,144 

Europe

 

 

 5,688 

 

 

 5,408 

 

 

 10,877 

 

 

 10,169 

Asia

 

 

 3,785 

 

 

 3,262 

 

 

 6,436 

 

 

 5,990 

Other international

 

 

 224 

 

 

 130 

 

 

 389 

 

 

 309 

Total international

 

 

 9,697 

 

 

 8,800 

 

 

 17,702 

 

 

 16,468 

Total revenue

 

$

 45,231 

 

$

 39,672 

 

$

 86,504 

 

$

 75,612 



United States revenue by product type was as follows:







 

 

 

 

 

 

 

 

 

 

 

 



 

 

 

 

 

 

 

 

 

 

 

 



 

Three Months Ended

 

Six Months Ended



 

June 30,

 

June 30,



 

2017

 

2016

 

2017

 

2016

Open-heart ablation

 

$

 16,790 

 

$

 14,721 

 

$

 32,495 

 

$

 28,689 

Minimally invasive ablation

 

 

 8,725 

 

 

 7,990 

 

 

 17,007 

 

 

 14,715 

AtriClip

 

 

 9,463 

 

 

 7,348 

 

 

 18,165 

 

 

 14,196 

Total ablation and AtriClip

 

 

 34,978 

 

 

 30,059 

 

 

 67,667 

 

 

 57,600 

Valve tools

 

 

 556 

 

 

 813 

 

 

 1,135 

 

 

 1,544 

Total United States

 

$

 35,534 

 

$

 30,872 

 

$

 68,802 

 

$

 59,144 



International revenue by product type was as follows:







 

 

 

 

 

 

 

 

 

 

 

 



 

 

 

 

 

 

 

 

 

 

 

 



 

Three Months Ended

 

Six Months Ended



 

June 30,

 

June 30,



 

2017

 

2016

 

2017

 

2016

Open-heart ablation

 

$

 5,674 

 

$

 5,438 

 

$

 10,264 

 

$

 9,910 

Minimally invasive ablation

 

 

 2,135 

 

 

 2,186 

 

 

 4,093 

 

 

 4,350 

AtriClip

 

 

 1,777 

 

 

 1,024 

 

 

 3,172 

 

 

 1,889 

Total ablation and AtriClip

 

 

 9,586 

 

 

 8,648 

 

 

 17,529 

 

 

 16,149 

Valve tools

 

 

 111 

 

 

 152 

 

 

 173 

 

 

 319 

Total international

 

$

 9,697 

 

$

 8,800 

 

$

 17,702 

 

$

 16,468 

The Company’s long-lived assets are located primarily in the United States, except for $870 as of June 30, 2017 and $931 as of December 31, 2016, which are located primarily in Europe.